Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

AIM

AIM ImmunoTech Inc.

Healthcare · USD

Set alert

Price alert · AIM

All alert types
0.15 USD -0.01 -4.04%
As of Oct 30, 2026 Extended hours 0.16 +3.56%
Bid
0.15 × 100
Ask
0.17 × 300
0.1545 Day range 0.1638
0.1545 52-week range 2.15
YTD
-85.95%
1 year
-92.81%
Open
0.164
Prev close
0.161
Mkt cap
6.16M
Vol
386.13K
Avg vol
4.70M
EPS
-2.98
P/E
0.00
Div yield
0.00%
More statistics
Low
0.1545
High
0.1638
Forward P/E
-0.48
Beta
-0.36
Short ratio
1.63
Inst. own
14.07%
Dividend
0.00
Ex-div date
50-d avg
0.232
200-d avg
0.338
1y target
2.75

5D chart

Chart tools
Interval
1m5m15m30m
AIM five-day price chart0.150.160.160.170.17Oct 22Oct 23Oct 26Oct 27Oct 28

Financial health

Altman Z-Score

-51.36 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 2
  • P/E 1
  • P/B 5

Valuation

P/E -0.1×
FY 2016: -5.3×FY 2017: -3.1×FY 2018: -2.1×FY 2019: -0.5×FY 2020: -10.3×FY 2021: -5.9×FY 2022: -2.0×FY 2023: -1.9×FY 2024: -1.7×FY 2025: -0.1×
FY 2016 5y median -1.9× FY 2025
P/S 20.8×
FY 2016: 424×FY 2017: 59.6×FY 2018: 56.2×FY 2019: 36.4×FY 2020: 907×FY 2021: 837×FY 2022: 274×FY 2023: 274×FY 2024: 171×FY 2025: 20.8×
FY 2016 5y median 274× FY 2025
P/B -0.2×
FY 2016: 2.5×FY 2017: 3.0×FY 2018: 4.0×FY 2019: 0.4×FY 2020: 2.4×FY 2021: 2.0×FY 2022: 1.0×FY 2023: 5.4×FY 2024: -22.0×FY 2025: -0.2×
FY 2016 5y median 1.0× FY 2025
P/FCF -0.2×
FY 2016: -5.0×FY 2017: -3.2×FY 2018: -1.9×FY 2019: -0.5×FY 2020: -13.5×FY 2021: -8.1×FY 2022: -2.4×FY 2023: -2.5×FY 2024: -1.9×FY 2025: -0.2×
FY 2016 5y median -2.4× FY 2025
EV/EBITDA -0.4×
FY 2016: -5.8×FY 2017: -3.7×FY 2018: -3.1×FY 2019: -1.2×FY 2020: -8.6×FY 2021: -4.4×FY 2022: -0.6×FY 2023: -1.8×FY 2024: -1.8×FY 2025: -0.4×
FY 2016 5y median -1.8× FY 2025
EV/Sales 65.8×
FY 2016: 398×FY 2017: 60.5×FY 2018: 71.5×FY 2019: 71.5×FY 2020: 685×FY 2021: 600×FY 2022: 88.2×FY 2023: 251×FY 2024: 178×FY 2025: 65.8×
FY 2016 5y median 178× FY 2025
FCF Yield -619.7%
FY 2016: -20.1%FY 2017: -30.8%FY 2018: -52.2%FY 2019: -184.8%FY 2020: -7.4%FY 2021: -12.4%FY 2022: -42.4%FY 2023: -39.4%FY 2024: -51.3%FY 2025: -619.7%
FY 2016 5y median -42.4% FY 2025

Profitability

Gross Margin -284.1%
FY 2016: -1104.3%FY 2017: -170.7%FY 2018: -140.9%FY 2019: -537.9%FY 2020: -394.5%FY 2021: -529.6%FY 2022: 100.0%FY 2023: 79.2%FY 2024: 81.8%FY 2025: -284.1%
FY 2016 5y median 79.2% FY 2025
Operating Margin -11961.4%
FY 2016: -15004.3%FY 2017: -2612.4%FY 2018: -3132.4%FY 2019: -8887.9%FY 2020: -9295.7%FY 2021: -13954.1%FY 2022: -14129.7%FY 2023: -15800.0%FY 2024: -11630.6%FY 2025: -11961.4%
FY 2016 5y median -13954.1% FY 2025
Net Margin -15861.4%
FY 2016: -8154.3%FY 2017: -1889.9%FY 2018: -2673.8%FY 2019: -6717.1%FY 2020: -8834.4%FY 2021: -14168.1%FY 2022: -13790.8%FY 2023: -14337.6%FY 2024: -10188.2%FY 2025: -15861.4%
FY 2016 5y median -14168.1% FY 2025
ROE 142.7%
FY 2016: -48.4%FY 2017: -94.9%FY 2018: -189.7%FY 2019: -72.9%FY 2020: -23.5%FY 2021: -33.6%FY 2022: -50.5%FY 2023: -283.0%FY 2024: 1310.1%FY 2025: 142.7%
FY 2016 5y median -33.6% FY 2025
ROIC -313.6%
FY 2016: -84.0%FY 2017: -99.3%FY 2018: -94.5%FY 2019: -64.3%FY 2020: -13.8%FY 2021: -33.0%FY 2022: -50.7%FY 2023: -291.4%FY 2024: -1221.2%FY 2025: -313.6%
FY 2016 5y median -291.4% FY 2025
ROA -241.4%
FY 2016: -39.7%FY 2017: -58.1%FY 2018: -70.9%FY 2019: -46.5%FY 2020: -13.0%FY 2021: -33.1%FY 2022: -48.0%FY 2023: -149.4%FY 2024: -201.2%FY 2025: -241.4%
FY 2016 5y median -149.4% FY 2025

Growth (YoY)

Revenue -48.2%
FY 2016: -30.8%FY 2017: 375.0%FY 2018: -16.0%FY 2019: -61.9%FY 2020: 16.4%FY 2021: -17.2%FY 2022: 4.4%FY 2023: 43.3%FY 2024: -15.8%FY 2025: -48.2%
FY 2016 FY 2025
Operating Income 46.8%
FY 2016: 17.1%FY 2017: 17.3%FY 2018: -0.7%FY 2019: -8.2%FY 2020: -21.8%FY 2021: -24.3%FY 2022: -5.8%FY 2023: -60.2%FY 2024: 38.0%FY 2025: 46.8%
FY 2016 FY 2025
EPS (diluted) 23.2%
FY 2016: 52.8%FY 2017: 14.7%FY 2018: 23.3%FY 2019: 73.6%FY 2020: 82.5%FY 2021: 10.7%FY 2022: -0.2%FY 2023: -47.3%FY 2024: 48.1%FY 2025: 23.2%
FY 2016 FY 2025
Free Cash Flow 24.0%
FY 2016: 52.6%FY 2017: -2.2%FY 2018: -34.4%FY 2019: 12.4%FY 2020: -16.2%FY 2021: -27.8%FY 2022: -16.9%FY 2023: -33.4%FY 2024: 31.8%FY 2025: 24.0%
FY 2016 FY 2025

Financial Health

Current Ratio 0.5×
FY 2016: 2.9×FY 2017: 1.3×FY 2018: 0.7×FY 2019: 9.3×FY 2020: 36.6×FY 2021: 74.6×FY 2022: 26.7×FY 2023: 1.7×FY 2024: 0.4×FY 2025: 0.5×
FY 2016 5y median 1.7× FY 2025
Quick Ratio 0.5×
FY 2016: 2.9×FY 2017: 1.3×FY 2018: 0.7×FY 2019: 9.3×FY 2020: 36.6×FY 2021: 74.6×FY 2022: 26.7×FY 2023: 1.7×FY 2024: 0.4×FY 2025: 0.5×
FY 2016 5y median 1.7× FY 2025
Debt / Equity -0.5×
FY 2016: 0.0×FY 2017: 0.2×FY 2018: 1.1×FY 2019: 0.5×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.1×FY 2024: -2.2×FY 2025: -0.5×
FY 2016 5y median 0.0× FY 2025
Net Debt / EBITDA -0.3×
FY 2016: 0.4×FY 2017: -0.1×FY 2018: -0.7×FY 2019: -0.6×FY 2020: 2.8×FY 2021: 1.7×FY 2022: 1.4×FY 2023: 0.2×FY 2024: -0.1×FY 2025: -0.3×
FY 2016 5y median 0.2× FY 2025
Interest Coverage -13.0×
FY 2016: 0.0×FY 2017: -82.1×FY 2018: -22.9×FY 2019: -29.1×FY 2020: -22.5×FY 2021: -281×FY 2022: 0.0×FY 2023: 0.0×FY 2024: -33.8×FY 2025: -13.0×
FY 2016 5y median -13.0× FY 2025

Dividends

Dividend Yield 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%FY 2025: 0.0%
FY 2016 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-12-31